The National Cancer Institute (NCI) has revised its criteria for NCI-funded trials to expand eligibility to individuals with pre-existing conditions, and provide opportunities for patients younger than 18 to participate in adult clinical trials. The new guidance helps to ensure that participants in clinical trials better reflect patients who will receive cancer therapies in routine clinical practice. (Health IT Analytics)